Literature DB >> 8674287

Value of SPECT imaging of the thoracolumbar spine in cancer patients.

E S Delpassand1, J R Garcia, V Bhadkamkar, D A Podoloff.   

Abstract

The purpose of this study was to evaluate the usefulness of SPECT bone imaging in targeting the precise location of vertebral abnormalities to ascertain whether such knowledge would help in differentiating between metastatic and benign lesions. SPECT images of the thoracolumbar spine in 50 patients were correlated with plain x-rays, CT, MRI, PET, and bone scans and 6-month clinical follow-ups. SPECT images revealed 110 lesions, 35 of which were metastases. Twenty-four of 25 lesions involving the vertebral body with extension into posterior elements were metastases, as well as 10 of 39 lesions found in the vertebral body and 1 of 4 found in the spinous process. All lesions limited to the anterior aspect of the vertebral body (13/13), facet joints (23/23), and intervertebral disk space (6/6) were benign. In conclusion, SPECT imaging of the thoracolumbar spine is helpful in determining the precise anatomic location of vertebral abnormalities, and knowledge of the location can be used to determine whether these abnormalities in cancer patients are benign entities or metastases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8674287     DOI: 10.1097/00003072-199512000-00001

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  2 in total

1.  Verification of phantom accuracy using a Monte Carlo simulation: bone scintigraphy chest phantom.

Authors:  Toshimune Ito; Hirotatsu Tsuchikame; Hajime Ichikawa; Masahisa Onoguchi; Koichi Okuda; Takayuki Shibutani; Noriyo Yokotsuka; Hiroshi Tomizawa
Journal:  Radiol Phys Technol       Date:  2021-07-24

2.  Current state of bone scintigraphy protocols and practice in Japan.

Authors:  Hajime Ichikawa; Kenta Miwa; Koichi Okuda; Takayuki Shibutani; Toyohiro Kato; Akio Nagaki; Hiroyuki Tsushima; Masahisa Onoguchi
Journal:  Asia Ocean J Nucl Med Biol       Date:  2020
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.